Down-regulation of Z39Ig on macrophages by IFN-γ in patients with chronic HBV infection

Clinical Immunology

Volumn 136, Issue 2, 2010, Pages 282-291

  Guo, Sheng ^a   Yang, Chengying ^a   Mei, Feng ^a   Wu, Shengxi ^a   Luo, Na ^a   Fei, Lei ^a   Chen, Yongwen ^a   Wu, Yuzhang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

B7 family; HBV; IFN ; Macrophage; Z39Ig

Indexed keywords

ALANINE AMINOTRANSAMINASE; CELL PROTEIN; GAMMA INTERFERON; LIVER ENZYME; PROTEIN Z391G; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME BLOOD LEVEL; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER BIOPSY; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ADOLESCENT; ADULT; DOWN-REGULATION; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-GAMMA; LIVER; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, COMPLEMENT; YOUNG ADULT;

EID: 77954311948     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.03.007     Document Type: Article

References (24)

1. Wu Y.Z., Zhang J.B., Chen S., Chen A., Wang L., Li J.T., Zhao T.T., Zou L.Y., Tang Y., Li T., Wang F. Frequencies of epitope-specific cytotoxic T lymphocytes in active chronic viral hepatitis B infection by using MHC class i peptide tetramers. Immunol. Lett. 2004, 92:253-257.
2. Blackburn S.D., Shin H., Haining W.N., Zou T., Workman C.J., Polley A., Betts M.R., Freeman G.J., Vignali D.A., Wherry E.J. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 2009, 10:29-37.
3. Rehermann B., Lau D., Hoofnagle J.H., Chisari F.V. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest. 1996, 97:1655-1665.
4. Maini M.K., Boni C., Ogg G.S., King A.S., Reignat S., Lee C.K., Larrubia J.R., Webster G.J., McMichael A.J., Ferrari C., Williams R., Vergani D., Bertoletti A. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 1999, 117:1386-1396.
5. Dong H.D., Strome D.E., Matteson E.L., Moder K.G., Flies D.B., Zhu G.F., Tamura H., Driscoll C.L., Chen L.P. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J. Clin. Invest. 2003, 111:363-370.
6. Collins M., Ling V., Carreno B.M. The B7 family of immune-regulatory ligands. Genome Biol. 2005, 6:223.
7. Flies D.B., Chen L. Modulation of immune response by B7 family molecules in tumor microenvironments. Immunol. Invest. 2006, 35:395-418.
8. Keir M.E., Sharpe A.H. The B7/CD28 costimulatory family in autoimmunity. Immunol. Rev. 2005, 204:128-143.
9. Leibson P.J. The regulation of lymphocyte activation by inhibitory receptors. Curr. Opin. Immunol. 2004, 16:328-336.
10. Wang F.S., Xing L.H., Liu M.X., Zhu C.L., Liu H.G., Wang H.F., Lei Z.Y. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J. Gastroenterol. 2001, 7:537-541.
11. Vogt L., Schmitz N., Kurrer M.O., Bauer M., Hinton H.I., Behnke S., Gatto D., Sebbel P., Beerli R.R., Sonderegger I., Kopf M., Saudan P., Bachmann M.F. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J. Clin. Invest. 2006, 116:2817-2826.
12. Helmy K.Y., Katschke K.J., Gorgani N.N., Kljavin N.M., Elliott J.M., Diehl L., Scales S.J., Ghilardi N., van Lookeren Campagne M. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006, 125:915-927.
13. Lee M.Y., Kim W.J., Kang Y.J., Jung Y.M., Kang Y.M., Suk K., Park J.E., Choi E.M., Choi B.K., Kwon B.S., Lee W.H. Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis. J. Leukoc. Biol. 2006, 80:922-928.
14. Sprengers D., van der Molen R.G., Kusters J.G., Hansen B., Niesters H.G.M., Schalm S.W., Janssen H.L.A. Different composition of intrahepatic lymphocytes in the immunetolerance and immune-clearance phase of chronic hepatitis B. J. Med. Virol. 2006, 78:561-568.
15. Zhang Z., Chen D., Yao J., Zhang H., Jin L., Shi M., Zhang H., Wang F.S. Increased infiltration of intrahepatic DC subsets closely correlate with viral control and serum aminotransferase in immune active pediatric patients with chronic hepatitis B. Clin. Immunol. 2007, 122:173-180.
16. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., Sharpe A.H. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 2003, 33:2706-2716.
17. P'ng L., James P.A. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5336-5341.
18. Chambers C.A., Allison J.P. Co-stimulation in T cell responses. Curr. Opin. Immunol. 1997, 9:369-404.
19. Xie Z., Chen Y., Zhao S., Yang Z., Yao X., Guo S., Yang C., Fei L., Zeng X., Ni B., Wu Y. Intrahepatic PD-1/PD-L1 up-regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection. Immunol. Invest. 2009, 38:624-638.
20. Roland C.R., Walp L., Stack R.M., Flye M.W. Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-gamma. J. Immunol. 1994, 153:5453-5464.
21. You Q., Cheng L., Kedl R.M., Ju C. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 2008, 48:978-990.
22. Kuniyasu Y., Marfani S.M., Inayat I.B., Sheikh S.Z., Mehal W.Z. Kupffer cells required for high affinity peptide-induced deletion, not retention, of activated CD8+ T cells by mouse liver. Hepatology 2004, 39:1017-1027.
23. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Schreiber R., Chisari FV F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996, 4:25-36.
24. Murray J.M., Wieland S.F., Purcell R.H., Chisari F.V. Dynamics of hepatitis B virus clearance in chimpanzees. Proc. Natl Acad. Sci. U.S.A. 2005, 102:17780-17785.